RG002C0106 injection
Drug timelines are a Plus or Pro feature.
2 regulatory and trial events tracked for RG002C0106 injection, covering 2025-12-26 to 2026-03-03. Get the full timeline:
Most recent: Clinical Trial Update: A Study of RG002C0106 Injection in Adult Participants With Normal Renal Function and Mild-to-Moderate Renal Impairment [Phase 1]